• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: B. BRAUN SURGICAL, S.A. OPTILENE 4/0 (1,5) 45CM DS19 (M) RCP; OTHER SUTURE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

B. BRAUN SURGICAL, S.A. OPTILENE 4/0 (1,5) 45CM DS19 (M) RCP; OTHER SUTURE Back to Search Results
Model Number C3090220
Device Problems Material Frayed (1262); Detachment of Device or Device Component (2907); Material Integrity Problem (2978)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  malfunction  
Event Description
It was reported an issue with optilene suture.The client reported that the thread fibrils and loosens when sewing.So far no adverse effect on the patient.Other patient details unknown.Tissue type: skin.Type of suture technique: single button suture/ back stitch suture.Prolapse during skin suture.Additional information has not been provided.
 
Manufacturer Narrative
Analysis and results: there are no previous complaints of this code-batch.We manufactured and distributed in the market (b)(4) units of this code-batch.There are no units in our stock.We have received 41 closed samples for analysis.Visually, thread surface appearance of closed samples received is correct and the usual one.We have tested the needle attachment strength of the samples received and the results fulfil the requirements of the european pharmacopoeia (ep): 1.20 kgf in average and 0.73 kgf in minimum (ep requirements: 0.46 kgf in average and 0.23 kgf in minimum) sewing test on artificial skin tissue has been conducted with the samples received and splitting/fraying does not appear when pulling the thread through the tissue.Visual appearance of the thread is the usual one.We have also tested the knot pull tensile strength of the samples received and the results fulfil the requirements of the european pharmacopoeia (ep): 1.28 kgf in average and 1.23 kgf in minimum (ep requirements: 0.51 kgf in average and 0.15 kgf in minimum) reviewed the batch manufacturing record, this product had a normal process and the results during the process fulfil usp/ep and b.Braun surgical requirements.Remarks: when working with optilene® suture material, great care should be taken to avoid any crushing or crimping damage of the monofilament by instruments such as forceps or needle holders.Final conclusion: although the results of the samples received fulfil the specifications of european pharmacopoeia/ b.Braun surgical specifications, we take note of this incidence in order to assess if new or additional actions are needed.Actions on product distributed of this reference/batch: based on the conclusion derived from investigation, it is not required to make actions in distributed product.Corrective/preventive actions: according to our internal procedures, there is no need to establish corrective or preventive actions.Nevertheless, this complaint is recorded for trending analysis to assess if actions are needed in the future.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTILENE 4/0 (1,5) 45CM DS19 (M) RCP
Type of Device
OTHER SUTURE
Manufacturer (Section D)
B. BRAUN SURGICAL, S.A.
carretera de terrassa 121
rubí, barcelona 08191
SP  08191
Manufacturer (Section G)
B. BRAUN SURGICAL, S.A.
carretera de terrassa 121
rubí, barcelona 08191
SP   08191
Manufacturer Contact
martina laporte
carretera de terrassa 121
rubí, barcelona 08191
SP   08191
MDR Report Key17788436
MDR Text Key323922355
Report Number3003639970-2023-00303
Device Sequence Number1
Product Code GAW
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K133890
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 09/21/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/21/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberC3090220
Device Catalogue NumberC3090220
Device Lot Number123213
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/05/2023
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/24/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/24/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-